In the opening minutes of the ADA Scientific Sessions Conference in Boston, Medtronic struck the first blow to win hearts and minds. The medical device manufacturer announced in a series of press releases a new FDA green light and two new partnerships all aimed at helping people with diabetes to access and share pump and continuous glucose monitor (CGM) readings in the cloud.
The biggest of the three announcements was Medtronic’s MiniMed Connect has received FDA clearance. The small device allows Medtronic insulin pump and CGM users to upload and share their data in a secure, cloud-based setting, according to the press release. The move could be viewed as an effort for the company to keep up with Dexcom’s strides in creating ways to access and share blood sugar readings and data in a cloud-based setting.
Perhaps not coincidentally, Medtronic also has announced it has partnered with Glooko, a diabetes data management company, and Samsung Electronics. The press releases for the partnerships emphasize that the relationships will help Medtronic with mobile and cloud data for diabetes management.
To read the press releases, click here:
Thanks for reading this Insulin Nation article. Want more Type 1 news? Subscribe here.
Have Type 2 diabetes or know someone who does? Try Type 2 Nation, our sister publication.